RETURN TO CHANNEL

Search Captions & Ask AI

THEY'RE LYING TO YOU ABOUT PEPTIDES!

April 23, 2026 / 01:41

This episode discusses the FDA's upcoming consideration of seven peptides for reclassification from category 2 to category 1, which would legalize them. Key peptides mentioned include BPC 157, TV500, KPV, MC, DIP, and CAX, each with specific benefits related to injury repair, blood flow, cognitive function, and metabolic rate.

The conversation highlights BPC 157's role in injury repair and TV500's ability to improve blood flow to damaged areas. These peptides are described as essential for tissue rebuilding and recovery.

Additionally, KPV is noted for its link to angiogenesis, while MC is discussed as a mitochondrial peptide that enhances exercise performance by increasing ATP production.

DIP and CAX are also mentioned for their effects on cognitive function and sleep regulation, indicating a broad range of potential health benefits from these peptides.

TLDR

FDA may legalize seven peptides, enhancing injury repair and cognitive function.

Episode

1:41

00:00:00

There was some significant news today. >> Correct. Yeah. >> What's going on? And just for anyone

00:00:04

that doesn't know, it's April the 15th. >> We got a press release from the FDA

00:00:09

saying that in July they are going to consider seven peptides for removing from category 2 back to category 1,

00:00:17

>> legalizing them. >> Legalizing them. Some of the heavy hitters from that list include BPC uh

00:00:24

157, >> which is the one we talked about to do with like repair and injury.

00:00:27

>> Absolutely. And then we have uh the brother to that which is TV500. This

00:00:33

vial over here, this improves blood flow to an injured area. You could think of this as sending the soldiers as sending

00:00:40

the cells that are required for rebuilding that tissue matrix that was damaged by a tear or a cut. We're also

00:00:46

getting something called uh KPV that is another uh peptide that has been linked to angioenesis and tissue repair. We're

00:00:55

also getting M C. MC is the uh mitochondrial peptide that has shown uh upregulation of basil metabolic rate and

00:01:04

has been very helpful and you know some patients will call it exercise in a vial. It improves your V2 max and your

00:01:10

exercise tolerance and by up uh regulating the energy pathway basically making more ATP the energy that we all

00:01:16

use to move it makes more of that available. We're also going to get uh DIP uh epiallon and CAX which are all uh

00:01:25

peptides that affect cognitive function. So improving thinking like uh CAX is a great option for that. And then uh DIP

00:01:33

and epathylon both have roles in regulating uh sleep and recovery. >> Wow.

00:01:38

>> Yeah. Pretty wild.

Badges

This episode stands out for the following:

60
Best concept / idea

Episode Highlights

FDA Considers Peptide Legalization
The FDA plans to consider legalizing seven peptides, including BPC 157, in July.
“Legalizing them. Some of the heavy hitters from that list include BPC.”
@ 00m 17s
April 23, 2026
Peptides for Injury Repair
BPC 157 and TV500 are highlighted for their roles in tissue repair and blood flow.
“This improves blood flow to an injured area.”
@ 00m 26s
April 23, 2026
Cognitive Function Peptides
DIP and CAX peptides are linked to improved cognitive function and sleep recovery.
“CAX is a great option for that.”
@ 01m 30s
April 23, 2026

Episode Quotes

Legalizing them. Some of the heavy hitters from that list include BPC.
THEY'RE LYING TO YOU ABOUT PEPTIDES!
This improves blood flow to an injured area.
THEY'RE LYING TO YOU ABOUT PEPTIDES!
It's exercise in a vial.
THEY'RE LYING TO YOU ABOUT PEPTIDES!

Key Moments

FDA Announcement00:06
Peptide List00:11
Tissue Repair00:37
Cognitive Function01:27